Biotech Startup Mekonos Raises Oversubscribed $25 Million Round To Overcome Pharma Industry'S Cell & Gene Therapy Delivery Hurdles
Amount Raised
$25 Million
Round Type
Funding Round
Description
Mekonos, a biotech company building the future of cell therapies on a chip, has raised $25M in an oversubscribed Series A round co-led by Reimagined Ventures, Fiscus Ventures, and PEAK6 Strategic Capital, a division of PEAK6 Investments. New institutional and strategic investors, including Section 32, Sands Capital, TDK Ventures, and the venture arm of Debiopharm, and previous investors, including Novartis Pharma AG (dRx Capital) and Elementum Ventures, also joined in the funding round that will support Mekonos' next stages in product development and commercialization.
Quick answer
Mekonos, Inc. raised $25 Million in a Funding Round round, dated November 9, 2021. Mekonos, Inc. is based in San Francisco, California, United States.
- How much did Mekonos, Inc. raise?
- Mekonos, Inc. raised $25 Million in a Funding Round round on November 9, 2021.
- What does Mekonos, Inc. do?
- Mekonos is a Silicon Valley Venture-backed Life Sciences company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in cell & gene therapies and cell line..
- Where is Mekonos, Inc. based and how big is it?
- Mekonos, Inc. is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Community And Lifestyle and Health Care around the same time
Companies in the same sectors as Mekonos, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Cresco Labs raised $62M on December 21, 2021.
- PetPlate, Inc. raised $16M on December 17, 2021.
- Well raised $70M (Series B) on December 17, 2021.
- The Valens Company raised $32M (Debt Financing) on December 16, 2021.
- Day Three Labs Inc raised $4.4M (Seed) on December 16, 2021.
- Belong Health raised $40M (Series A) on December 15, 2021.
Who to call at Mekonos, Inc., and when
A new round usually means Mekonos, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Mekonos, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mekonos, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mekonos, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mekonos, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Mekonos, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.